QA: Johnson Johnson in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2025_Johnson_Johnson.pdf

Logs

Graph

Absolute values for 0000200406, Johnson Johnson

  xvar xval
0 AssetsCurrent 55,893,000,000
1 IntangibleAssetsNetIncludingGoodwill 81,818,000,000
2 PropertyPlantAndEquipmentNet 20,518,000,000
3 remainder_Assets 21,875,000,000
4 LiabilitiesCurrent 50,321,000,000
5 LiabilitiesNoncurrent 48,200,000,000
6 remainder_Liabilities 10,093,000,000
7 CostOfGoodsAndServicesSold 27,463,342,270
8 SellingGeneralAndAdministrativeExpense 22,808,104,148
9 ResearchAndDevelopmentExpense 17,408,594,963
10 remainder_Expenses 3,846,612,592
11 remainder_Revenues 88,735,652,583
12 remainder_NetIncome 13,400,730,625
13 remainder_ComprehensiveNetIncome -513,506,834
  yvar yval
0 Assets 180,104,000,000
1 Liabilities 108,614,000,000
2 Expenses 71,526,653,973
3 Revenues 88,735,652,583
4 StockholdersEquity 71,490,000,000
5 NetIncome 30,609,729,235
6 ComprehensiveNetIncome 30,352,975,818
7 BaseVar 231,447,272,008
8 EconomicCapitalRatiobeforeLimitedLiability 1.29
9 EconomicCapitalRatio 2.52

Edgar->Model Mapping

Feature Distribution

Change over Time